Newer magnetic resonance techniques and disease activity in multiple sclerosis: New concepts and new concerns

Multiple Sclerosis

Volumn 4, Issue 6, 1998, Pages 469-470

  Filippi, Massimo ^a   Silver, Nicholas C ^b   Yousry, Tarek A ^c   Miller, David H ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Disease activity; Gadolinium DTPA; Magnetic resonance imaging; Multiple sclerosis

Indexed keywords

GADOLINIUM PENTETATE;

DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; SHORT SURVEY;

EID: 0032435813     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/135245859800400601     Document Type: Short Survey

References (16)

1. Filippi M, Miller DH. (1996) MRI in the differential diagnosis and monitoring the treatment of multiple sclerosis. Curr Opin Neurol 9: 176-186.
2. Miller DH et al. (1996) Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. Ann Neurol 39: 6-16.
3. Katz D et al. (1993) Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol 31: 661-669.
4. McDonald WI, Miller DH, Barnes D. (1992) The pathological evolution of multiple sclerosis. Neuropathol Appl Neurobiol 18: 319-334.
5. Lai M et al. (1996) A preliminary study into the sensitivity of disease activity detection by serial weekly magnetic resonance imaging in multiple sclerosis. J Neurol Neurosurg Psychiatry 60: 339-341.
6. Thorpe JW et al. (1996) Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis. Neurology 46: 373-378.
7. Filippi M et al. (1997) Sensitivity of delayed gadolinium enhanced MRI in multiple sclerosis. Acta Neurol Scand 95: 331-334.
8. Filippi M et al. (1995) Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with primary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 59: 540-544.
9. Filippi M et al. (1996) Triple dose of gadolinium-DTPA and delayed MRI in patients with benign multiple sclerosis. J Neurol Neurosurg Psychiatry 60: 526-530.
10. Filippi M et al. (1996) Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with multiple sclerosis. Neurology 46: 379-384.
11. Filippi M et al. (1996) A high-resolution three-dimensional gradient echo sequence improves the detection of disease activity in multiple sclerosis. Ann Neurol 40: 901-907.
12. Motha RC, Pike B, Enzmann DR (1995) Improved detection of enhancing and nonenhancing lesions of multiple sclerosis with magnetization transfer. Am J Neuroradiol (AJNR) 16: 1771-1778.
13. Silver NC et al. (1997) Sensitivity of contrast enhanced MRI in multiple sclerosis: effects of gadolinium dose, magnetisation transfer contrast and delayed imaging. Brain 120: 1149-1161.
14. Bruck W et al. (1997) Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol 42: 783-793.
15. Filippi M et al. (1998) Magnetization transfer ratios in MS lesions enhancing after different doses of gadolinium. Neurology in press.
16. Grossman RI. (1994) Magnetization transfer in multiple sclerosis. Ann Neurol 36: S97-S99.